There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

S.BIOMEDICS reported that TED-A9, an investigational cell therapy for Parkinson's disease, showed positive data during the Phase 1/2a trial.

Viridian Therapeutics Announces Positive Long-Term Durability Data from the Veligrotug Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease (TED) - 70% of patients treated ...

S.BIOMEDICS announced encouraging one-year post-transplant results from Phase 1/2a clinical trial evaluating A9-DPC cell ...

Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian ...

Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2 ...

Conservative Sen. Ted Cruz (Texas) on Monday pointed to what he called the “anti-capitalist” views of the 26-year-old man named as a person of interest in the investigation of the shooting ...

Ted Cruz calls suspected UnitedHealthcare CEO shooter proof leftism is a “mental disease” Commenting on Luigi Mangione's embrace of climate-change causes, Cruz says support from "leftists" has ...